These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38269277)

  • 1. Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations.
    Suleman M; Ahmad T; Shah K; Albekairi NA; Alshammari A; Khan A; Wei DQ; Yassine HM; Crovella S
    Front Pharmacol; 2023; 14():1328308. PubMed ID: 38269277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations.
    Khan A; Adil S; Qudsia HA; Waheed Y; Alshabrmi FM; Wei DQ
    Comput Biol Med; 2023 May; 158():106797. PubMed ID: 36966556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I.
    Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase.
    Rabaan AA; Alwashmi ASS; Mashraqi MM; Alshehri AA; Alawfi A; Alshengeti A; Najim MA; AlShehail BM; AlShahrani AJ; Garout M
    Mol Divers; 2023 Aug; ():. PubMed ID: 37531040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
    Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD).
    Sayaf AM; Ullah Khalid S; Hameed JA; Alshammari A; Khan A; Mohammad A; Alghamdi S; Wei DQ; Yeoh K
    Front Pharmacol; 2023; 14():1202128. PubMed ID: 37670941
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of Antiviral Compounds against Monkeypox Virus Profilin-like Protein A42R from
    Bajrai LH; Alharbi AS; El-Day MM; Bafaraj AG; Dwivedi VD; Azhar EI
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of ORF8-IRF3 binding interface with Carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches.
    Suleman M; Murshed A; Imran K; Khan A; Ali Z; Albekairi NA; Wei DQ; Yassine HM; Crovella S
    BMC Chem; 2024 May; 18(1):99. PubMed ID: 38734638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Traditional Chinese Medicine (TCM) database chemical space to target I7L protease from monkeypox virus using molecular screening and simulation approaches.
    Khan A; Shahab M; Nasir F; Waheed Y; Alshammari A; Mohammad A; Zichen G; Li R; Wei DQ
    SAR QSAR Environ Res; 2023; 34(9):689-708. PubMed ID: 37675795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays.
    Mills MG; Juergens KB; Gov JP; McCormick CJ; Sampoleo R; Kachikis A; Amory JK; Fang FC; Pérez-Osorio AC; Lieberman NAP; Greninger AL
    J Clin Virol; 2023 Feb; 159():105373. PubMed ID: 36603329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of natural compounds against the human mpox virus DNA-dependent RNA polymerase in silico.
    Abduljalil JM; Elfiky AA; Elgohary AM
    J Infect Public Health; 2023 Jul; 16(7):996-1003. PubMed ID: 37167647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study.
    Rabaan AA; Alshahrani FS; Garout M; Alissa M; Mashraqi MM; Alshehri AA; Alsaleh AA; Alwarthan S; Sabour AA; Alfaraj AH; AlShehail BM; Alotaibi N; Abduljabbar WA; Aljeldah M; Alestad JH
    Mol Divers; 2024 Apr; ():. PubMed ID: 38652365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
    Aziz S; Almajhdi FN; Waqas M; Ullah I; Salim MA; Khan NA; Ali A
    Front Immunol; 2022; 13():1004804. PubMed ID: 36311762
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Podduturi S; Vemula D; Singothu S; Bhandari V
    J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37555596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug and Anti-Viral Peptide Design to Inhibit the Monkeypox Virus by Restricting A36R Protein.
    Miah MM; Tabassum N; Afroj Zinnia M; Islam ABMMK
    Bioinform Biol Insights; 2022; 16():11779322221141164. PubMed ID: 36570327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
    Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
    J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease.
    Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Eltaib L; Alshehri A; Alsaiari AA; Kamal M; Alshammari AMA
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches.
    Tan C; Zhu F; Pan P; Wu A; Li C
    Front Immunol; 2023; 14():1112816. PubMed ID: 36993967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the medicinal potential of Dark Chemical Matters (DCM) to design promising inhibitors for PLpro of SARS-CoV-2 using molecular screening and simulation approaches.
    Khan A; Liaqat A; Masood A; Ali SS; Ali L; Alshammari A; Alasmari AF; Mohammad A; Waheed Y; Wei DQ
    Saudi Pharm J; 2023 Oct; 31(10):101775. PubMed ID: 37719892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
    Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
    J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.